IL-1 receptor accessory protein is an essential component of the IL-1 receptor

EB Cullinan, L Kwee, P Nunes, DJ Shuster… - The Journal of …, 1998 - journals.aai.org
EB Cullinan, L Kwee, P Nunes, DJ Shuster, G Ju, KW McIntyre, RA Chizzonite, MA Labow
The Journal of Immunology, 1998journals.aai.org
The recently described IL-1R accessory protein (IL-1R AcP) interacts with IL-1β and the IL-1
type-IR (IL-1RI), but an essential requirement for IL-1R AcP in IL-1 signaling in vitro has not
been established and its role in vivo has not been examined. In this study, IL-1R AcP-
deficient mice and fibroblasts were produced and characterized. All IL-1 agonists bound to
IL-1R AcP-deficient cells through the type I IL-1R, but failed to activate gene expression
through either the nuclear factor-κB or AP-1-dependent signaling pathways. Absence of IL …
Abstract
The recently described IL-1R accessory protein (IL-1R AcP) interacts with IL-1β and the IL-1 type-IR (IL-1RI), but an essential requirement for IL-1R AcP in IL-1 signaling in vitro has not been established and its role in vivo has not been examined. In this study, IL-1R AcP-deficient mice and fibroblasts were produced and characterized. All IL-1 agonists bound to IL-1R AcP-deficient cells through the type I IL-1R, but failed to activate gene expression through either the nuclear factor-κB or AP-1-dependent signaling pathways. Absence of IL-1R AcP differentially affected the affinity for IL-1 ligands. IL-1R AcP-deficient fibroblasts bound murine IL-1α and human IL-1R antagonist protein (IL-1Ra) with only moderately reduced affinity when compared with wild-type cells, whereas murine IL-1β affinity was reduced by 70-fold. IL-1 also failed to produce a biologic response in vivo in IL-1R AcP-deficient mice. These data demonstrate that a type I IL-1R/IL-1R AcP complex is required for signaling by all IL-1 agonists and for high affinity binding by IL-1β. Finally, IL-1R AcP is an essential signal transducing component of the functional IL-1R and should represent a novel target for blocking IL-1 function in human disease.
journals.aai.org